CARDIX-101
/ Cardix Therap
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 13, 2024
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
(clinicaltrials.gov)
- P1/2 | N=20 | Completed | Sponsor: Cardix Therapeutics LLC | Not yet recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Jun 2024 | Trial primary completion date: Dec 2024 ➔ Jun 2024
Trial completion • Trial completion date • Trial primary completion date • Cardiovascular
July 19, 2022
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
(clinicaltrials.gov)
- P1/2 | N=20 | Not yet recruiting | Sponsor: Cardix Therapeutics LLC | Trial completion date: Dec 2023 ➔ Dec 2024 | Trial primary completion date: Dec 2023 ➔ Dec 2024
Trial completion date • Trial primary completion date • Cardiovascular
March 09, 2022
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
(clinicaltrials.gov)
- P1/2 | N=20 | Not yet recruiting | Sponsor: Cardix Therapeutics LLC | Trial completion date: Sep 2023 ➔ Dec 2023 | Initiation date: Nov 2021 ➔ May 2022 | Trial primary completion date: Sep 2023 ➔ Dec 2023
Trial completion date • Trial initiation date • Trial primary completion date • Cardiovascular
1 to 3
Of
3
Go to page
1